The end of static whitepapers in life sciences: toward autonomous content ecosystems (opens in new tab)
Whitepapers have long been a cornerstone of thought leadership and lead generation in B2B marketing. In the pharmaceutical industry, they serve a unique role by translating clinical data into insights and commercial impact. However, traditional whitepapers are increasingly out of sync with how stakeholders discover information. This shift marks the end of static whitepapers
Read the original article